🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A retrospective observational study to evaluate immunohistochemical express...
Status
Unknown
Location
Sohag University hospitals
Start Date
2021-01-01
Trial ID
NCT05794737
Treatments Being Tested
The study will evaluate the efficacy and safety of two different dosing reg...
Status
Unknown
Location
Eye & Ent Hospital of Fudan University
Start Date
2013-12
Trial ID
NCT02810808
Treatments Being Tested
This is a prospective observational trial that will enroll pregnant women b...
Status
Completed
Location
Prof. Dr. Daniel Surbek
Start Date
2013-12
Trial ID
NCT02092688
Treatments Being Tested
MAD0004J08, the experimental drug, is a potent neutralizing IgG1 monoclonal...
Status
Unknown
Location
IRCCS INMI Lazzaro Spallanzani - Istituto nazionale Malattie Infettive
Start Date
2021-06-06
Trial ID
NCT04952805
Treatments Being Tested
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
This early phase I trial investigates how well 64Cu-labeled M5A antibody sc...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-08-31
Trial ID
NCT05245786
Treatments Being Tested
This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-10
Trial ID
NCT05182073
Hemophilia is an inherited bleeding disorder characterized by deficiency of...
Status
Completed
Location
Hayatabad Medical Complex
Start Date
2025-09-09
Trial ID
NCT07187661
Treatments Being Tested
The purpose of this study is to determine whether Infliximab (monoclonal an...
Status
Completed
Location
University Hospitals Birmingham NHS Foundation Trust
Start Date
2003-01
Trial ID
NCT00753103
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested